查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1418354

嗎啡市場報告：2030 年趨勢、預測與競爭分析

Morphine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

嗎啡趨勢和預測

預計2024年至2030年全球嗎啡市場將以8.1%的複合年成長率成長。市場的主要驅動力是癌症和其他疾病患者數量的迅速增加以及嗎啡在疼痛治療中的使用不斷增加。全球嗎啡市場的未來似乎在醫院/診所市場和門診手術中心市場有機會。

嗎啡市場洞察

Lucintel 預測，由於神經系統疾病的增加，注射劑在預測期內仍將是最大的細分市場。

由於處方數量較多，醫院和診所仍然是該市場中最大的部分。

由於慢性病的迅速增加，北美在預測期內將繼續成為最大的地區。

常問問題

Q1.市場成長預測如何？

A1. 2024年至2030年，全球嗎啡市場預計將以8.1%的複合年成長率成長。

Q2.影響市場成長的主要促進因素有哪些？

A2. 該市場的主要驅動力是癌症和其他疾病的迅速增加以及嗎啡在疼痛治療中的使用不斷增加。

Q3.市場的主要細分市場有哪些？

A3. 嗎啡市場前景廣闊，醫院和診所市場以及門診手術中心市場充滿機會。

Q4.市場上主要企業有哪些？

A4. 主要的嗎啡公司如下。

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health Care

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預計，由於神經系統疾病的增加，注射劑在預測期內仍將是其最大的細分市場。

Q6. 未來五年預計哪個地區將成為最大的市場？

A6. 由於慢性病的快速增加，北美在預測期內將繼續成為最大的地區。

Q7. 可以客製化報告嗎？

A7. 是的，Lucintel 提供 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球嗎啡市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球嗎啡市場趨勢（2018-2023）與預測（2024-2030）
  • 按劑型分類的全球嗎啡市場
    • 注射
    • 口服錠劑
    • 其他
  • 按分銷管道分類的全球嗎啡市場
    • 醫院藥房
    • 零售藥房
    • 網路藥房
    • 其他
  • 全球嗎啡市場的應用
    • 疼痛管理
    • 腹瀉抑制劑
    • 感冒和止咳藥
    • 其他
  • 按最終用途分類的全球嗎啡市場
    • 醫院和診所
    • 門診手術中心
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球嗎啡市場區域分佈
  • 北美嗎啡市場
  • 歐洲嗎啡市場
  • 亞太嗎啡市場
  • 其他地區嗎啡市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按劑型分類的全球嗎啡市場成長機會
    • 按分銷管道分類的全球嗎啡市場成長機會
    • 全球嗎啡市場成長機會（按應用）
    • 全球嗎啡市場成長機會（依最終用途）
    • 全球嗎啡市場成長機會（按地區）
  • 全球嗎啡市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球嗎啡市場產能擴張
    • 全球嗎啡市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health care
簡介目錄

Morphine Trends and Forecast

The future of the global morphine market looks promising with opportunities in the hospitals & clinics and ambulatory surgical centers markets. The global morphine market is expected to grow with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are surge in cancer and other disease cases accentuates and escalating utilization of morphine for pain management.

A more than 150-page report is developed to help in your business decisions.

Morphine by Segment

The study includes a forecast for the global morphine by dosage form, distrbution channel, application, end use, and region.

Morphine Market by Dosage Form [Shipment Analysis by Value from 2018 to 2030]:

  • Injection
  • Oral Tablets
  • Others

Morphine Market by Distrbution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Morphine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pain Management
  • Diarrhea Suppressant
  • Cold And Cough Suppressant
  • Others

Morphine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Morphine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Morphine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies morphine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the morphine companies profiled in this report include-

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health Care

Morphine Market Insights

Lucintel forecasts that injection will remain the largest segment over the forecast period due to growing occurrence of neurological diseases.

Within this market, hospitals and clinics will remain the largest segment due to high prescriptions.

North America will remain the largest region over the forecast period due to surging prevalence of chronic diseases.

Features of the Global Morphine Market

Market Size Estimates: Morphine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Morphine market size by various segments, such as by dosage form, distrbution channel, application, end use, and region in terms of value ($B).

Regional Analysis: Morphine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different dosage form, distrbution channel, application, end use, and regions for the morphine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the morphine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for morphine market?

Answer: The global morphine market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the morphine market?

Answer: The major drivers for this market are surge in cancer and other disease cases accentuates and escalating utilization of morphine for pain management.

Q3. What are the major segments for morphine market?

Answer: The future of the morphine market looks promising with opportunities in the hospitals & clinics and ambulatory surgical centers markets.

Q4. Who are the key morphine market companies?

Answer: Some of the key morphine companies are as follows.

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health Care

Q5. Which morphine market segment will be the largest in future?

Answer: Lucintel forecasts that injection will remain the largest segment over the forecast period due to growing occurrence of neurological diseases.

Q6. In morphine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surging prevalence of chronic diseases.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the morphine market by dosage form (injection, oral tablets, and others), distrbution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others), application (pain management, diarrhea suppressant, cold and cough suppressant, and others), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Morphine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Morphine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Morphine Market by Dosage Form
    • 3.3.1: Injection
    • 3.3.2: Oral Tablets
    • 3.3.3: Others
  • 3.4: Global Morphine Market by Distrbution Channel
    • 3.4.1: Hospital Pharmacies
    • 3.4.2: Retail Pharmacies
    • 3.4.3: Online Pharmacies
    • 3.4.4: Others
  • 3.5: Global Morphine Market by Application
    • 3.5.1: Pain Management
    • 3.5.2: Diarrhea Suppressant
    • 3.5.3: Cold and Cough Suppressant
    • 3.5.4: Others
  • 3.6: Global Morphine Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Morphine Market by Region
  • 4.2: North American Morphine Market
    • 4.2.3: North American Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.3: European Morphine Market
    • 4.3.1: European Morphine Market by Dosage Form: Injection, Oral Tablets, and Others
    • 4.3.3: European Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Morphine Market
    • 4.4.1: APAC Morphine Market by Dosage Form: Injection, Oral Tablets, and Others
    • 4.4.3: APAC Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Morphine Market
    • 4.5.1: ROW Morphine Market by Dosage Form: Injection, Oral Tablets, and Others
    • 4.5.3: ROW Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Morphine Market by Dosage Form
    • 6.1.2: Growth Opportunities for the Global Morphine Market by Distrbution Channel
    • 6.1.3: Growth Opportunities for the Global Morphine Market by Application
    • 6.1.4: Growth Opportunities for the Global Morphine Market by End Use
    • 6.1.5: Growth Opportunities for the Global Morphine Market by Region
  • 6.2: Emerging Trends in the Global Morphine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Morphine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Morphine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Mallinckrodt Pharmaceuticals
  • 7.2: Alcaliber
  • 7.3: Purdue Pharma
  • 7.4: Sanofi Winthrop Industries
  • 7.5: Macfarlan Smith
  • 7.6: Sun Pharmaceutical Industries
  • 7.7: Qinghai Pharmaceutical
  • 7.8: Northeast Pharmaceutical
  • 7.9: Pfizer
  • 7.10: Verve Health care